Claritev Corporation (CTEV)
NYSE: CTEV · Real-Time Price · USD
32.98
-0.97 (-2.86%)
Dec 8, 2025, 4:00 PM EST - Market closed
Claritev Revenue
Claritev had revenue of $245.96M in the quarter ending September 30, 2025, with 6.71% growth. This brings the company's revenue in the last twelve months to $951.00M, up 0.89% year-over-year. In the year 2024, Claritev had annual revenue of $930.62M, down -3.21%.
Revenue (ttm)
$951.00M
Revenue Growth
+0.89%
P/S Ratio
0.57
Revenue / Employee
$352,224
Employees
2,700
Market Cap
545.02M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 930.62M | -30.90M | -3.21% |
| Dec 31, 2023 | 961.52M | -118.19M | -10.95% |
| Dec 31, 2022 | 1.08B | -37.89M | -3.39% |
| Dec 31, 2021 | 1.12B | 179.84M | 19.18% |
| Dec 31, 2020 | 937.76M | -45.14M | -4.59% |
| Dec 31, 2019 | 982.90M | -57.98M | -5.57% |
| Dec 31, 2018 | 1.04B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
CTEV News
- 6 days ago - Claritev Corporation (CTEV) Presents at Bank of America Leveraged Finance Conference Transcript - Seeking Alpha
- 14 days ago - Claritev Corporation Announces Participation at Upcoming Conferences - Business Wire
- 26 days ago - Claritev Corporation Announces Pricing of Offering of Class A Common Stock by Selling Stockholders - Business Wire
- 26 days ago - Claritev Corporation Announces Public Offering of Class A Common Stock by Selling Stockholders - Business Wire
- 4 weeks ago - Claritev Corporation (CTEV) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Claritev Corporation Reports Third Quarter 2025 Results - Business Wire
- 6 weeks ago - Claritev Invests in Klaim, Inc. to Accelerate Provider Payment Solutions Across the U.S. and MENA Region - Business Wire
- 7 weeks ago - Claritev Corporation Announces Third Quarter 2025 Earnings Conference Call - Business Wire